Dermata Therapeutics, Inc. (NASDAQ: DRMA) stock rose Wednesday after the company disclosed that it has entered into definitive agreements for a private placement offering of around $12.4 million. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results